463 related articles for article (PubMed ID: 30484333)
1. Emerging drugs for migraine treatment: an update.
Lambru G; Andreou AP; Guglielmetti M; Martelletti P
Expert Opin Emerg Drugs; 2018 Dec; 23(4):301-318. PubMed ID: 30484333
[No Abstract] [Full Text] [Related]
2. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
3. Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives.
De Matteis E; Guglielmetti M; Ornello R; Spuntarelli V; Martelletti P; Sacco S
Expert Rev Neurother; 2020 Jun; 20(6):627-641. PubMed ID: 32434430
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans.
de Vries T; Villalón CM; MaassenVanDenBrink A
Pharmacol Ther; 2020 Jul; 211():107528. PubMed ID: 32173558
[TBL] [Abstract][Full Text] [Related]
5. Targeting CGRP and 5-HT
Moreno-Ajona D; Chan C; Villar-Martínez MD; Goadsby PJ
Headache; 2019 Jul; 59 Suppl 2():3-19. PubMed ID: 31291016
[TBL] [Abstract][Full Text] [Related]
6. European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention.
Sacco S; Bendtsen L; Ashina M; Reuter U; Terwindt G; Mitsikostas DD; Martelletti P
J Headache Pain; 2019 Jan; 20(1):6. PubMed ID: 30651064
[TBL] [Abstract][Full Text] [Related]
7. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Edvinsson L; Haanes KA; Warfvinge K; Krause DN
Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
[TBL] [Abstract][Full Text] [Related]
8. Role of CGRP in Migraine.
Edvinsson L
Handb Exp Pharmacol; 2019; 255():121-130. PubMed ID: 30725283
[TBL] [Abstract][Full Text] [Related]
9. Emerging drugs for the prevention of migraine.
Ogunlaja O; Karsan N; Goadsby P
Expert Opin Emerg Drugs; 2021 Sep; 26(3):271-280. PubMed ID: 34263680
[TBL] [Abstract][Full Text] [Related]
10. [Migraine Medication].
Kikui S; Takeshima T
Brain Nerve; 2023 May; 75(5):470-478. PubMed ID: 37194515
[TBL] [Abstract][Full Text] [Related]
11. Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():276-290. PubMed ID: 30403405
[TBL] [Abstract][Full Text] [Related]
12. Erenumab in the treatment of migraine.
Jain S; Yuan H; Spare N; Silberstein SD
Pain Manag; 2018 Nov; 8(6):415-426. PubMed ID: 30235976
[TBL] [Abstract][Full Text] [Related]
13. Rimegepant: acute treatment for migraine headaches.
Peters GL; Hennessey EK
Pain Manag; 2021 May; 11(3):259-266. PubMed ID: 33550872
[TBL] [Abstract][Full Text] [Related]
14. Treatment of migraine with monoclonal antibodies.
Serra López-Matencio JM; Gago-Veiga AB; Gómez M; Alañón Plaza E; Mejía GP; González-Gay MÁ; Castañeda S
Expert Opin Biol Ther; 2022 Jun; 22(6):707-716. PubMed ID: 35502612
[TBL] [Abstract][Full Text] [Related]
15. The use of erenumab for migraine prophylaxis during pregnancy: A case report and narrative review.
Vig SJ; Garza J; Tao Y
Headache; 2022 Nov; 62(10):1256-1263. PubMed ID: 35467013
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin Gene-Related Peptide (CGRP) Antagonists and Their Use in Migraines.
Henson B; Hollingsworth H; Nevois E; Herndon C
J Pain Palliat Care Pharmacother; 2020 Mar; 34(1):22-31. PubMed ID: 31763951
[TBL] [Abstract][Full Text] [Related]
17. Medications Approved for Preventing Migraine Headaches.
Spindler BL; Ryan M
Am J Med; 2020 Jun; 133(6):664-667. PubMed ID: 32145209
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Pharmacotherapy for Episodic Migraine.
Chan C; Goadsby PJ
CNS Drugs; 2019 Nov; 33(11):1053-1071. PubMed ID: 31556018
[TBL] [Abstract][Full Text] [Related]
19. PACAP38 and PAC
Rubio-Beltrán E; Correnti E; Deen M; Kamm K; Kelderman T; Papetti L; Vigneri S; MaassenVanDenBrink A; Edvinsson L;
J Headache Pain; 2018 Aug; 19(1):64. PubMed ID: 30088106
[TBL] [Abstract][Full Text] [Related]
20. The CGRP Pathway in Migraine as a Viable Target for Therapies.
Edvinsson L
Headache; 2018 May; 58 Suppl 1():33-47. PubMed ID: 29697153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
